Related Experiment Video
Updated: May 15, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
How Does HDL Participate in Atherogenesis? Antioxidant Activity Versus Role in Reverse Cholesterol Transport
Paul N Durrington1, Bilal Bashir1,2, Handrean Soran1,2
1Faculty of Biology, Medicine and Health, Cardiovascular Research Group, University of Manchester, Manchester M13 9NT, UK.
Modified LDL, particularly oxidized LDL (oxLDL), readily crosses the vascular endothelium, contributing to atheroma formation. High-density lipoprotein (HDL), via paraoxonase 1 (PON1), counteracts this process, offering therapeutic potential.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Lipid Metabolism
Background:
- Modified low-density lipoprotein (LDL), including oxidatively modified LDL (oxLDL) and glycatively modified LDL (glycLDL), readily penetrates the vascular endothelium.
- Oxidative stress from reactive oxygen species (ROS) contributes to LDL modification within the vascular and tissue compartments.
- High-density lipoprotein (HDL) possesses antioxidant properties, primarily attributed to paraoxonase 1 (PON1), which mitigates LDL modification.
Purpose of the Study:
- To elucidate the role of modified LDL in atherogenesis and the protective mechanisms mediated by HDL.
- To highlight the importance of PON1's lipid-associated activity in HDL's anti-atherogenic function.
Main Methods:
- Analysis of LDL modification by reactive oxygen species (ROS) and glucose.
- Investigation of high-density lipoprotein (HDL) antioxidant capacity, focusing on paraoxonase 1 (PON1) activity.
- Examination of the cellular uptake of modified LDL by monocytes and the subsequent formation of foam cells and atheroma.
Main Results:
- Oxidatively modified LDL (oxLDL) and glycatively modified LDL (glycLDL) are formed in circulation and tissue fluid, promoting endothelial crossing.
- Paraoxonase 1 (PON1), when associated with HDL's lipid environment, effectively hydrolyzes lipid peroxides, counteracting LDL modification.
- Modified LDL uptake by monocytes via scavenger receptors leads to foam cell formation, a key step in atheroma development.
Conclusions:
- HDL, through PON1's lipid-hydrolyzing activity, plays a crucial role in opposing atherogenesis.
- Understanding PON1's function within HDL offers a promising avenue for identifying individuals at risk and developing novel therapies for cardiovascular disease.
- The emphasis on PON1's role in HDL's protective mechanisms may be more therapeutically relevant than its role in reverse cholesterol transport.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Inflammation

